Conformal proton beam radiation therapy for prostate cancer: Concepts and clinical results

Community Oncology

Volumn 4, Issue 4, 2007, Pages 235-240

  Rossi Jr , Carl J ^a,b  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DOSIMETRY; DYSURIA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; NOCTURIA; PROCTITIS; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING; URINARY FREQUENCY; URINARY HESITANCY;

EID: 34248144406     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70095-X     Document Type: Article

References (26)

1. Rossi CJ Jr, Slater JD, Reves-Molyneux N, et al. Particle beam radiation therapy in prostate cancer: is there an advantage? Semin Radiat Oncol 1998;8:115-123.
2. Suit HD, Goitein M. Dose-limiting tissues in relation to types and location of tumours: implications for efforts to improve radiation dose distributions. Eur J Cancer 1974;10:217-224.
3. Austin-Seymour M, Urie M, Munzenrider J, et al. Considerations in fractionated proton radiation therapy: clinical potential and results. Radiother Oncol 1990;7:29-35.
4. Suit HD, Gotein M, Munzenrider J, et al. Increased efficacy of radiation therapy by use of proton beam. Strahlenther Onkol 1990;166:40-44.
5. Suit HD. Potential clinical gains by use of superior radiation dose distribution. NCI Proton Workshop. Int J Radiat Oncol Biol Phys 1992;22:233-234.
6. Hanks GE, Leibel SA, Krall JM, Kramer S. Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1985;11:153-157.
7. Brenner DJ, Hall EJ, Curtis RE, Ron E. Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum. Gastroenterology 2005;129:773-774; author's reply: 774-775.
8. Fowler JF. What can we expect from dose escalation using proton beams? Clin Oncol (R Coll Radiol) 2003;15:S10-S15.
9. Johansson B, Ridderheim M, Glimelius B. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers. Acta Oncol 2005;44:890-895.
10. Lundkvist J, Ekman M, Ericsson SR, Jonsson B, Glimelius B. Proton therapy of cancer: potential clinical advantages and cost-effectiveness. Acta Oncol 2005;44:850-861.
11. Schulte RW, Slater JD, Rossi CJ Jr, Slater JM. Value and perspectives of proton radiation therapy for limited stage prostate cancer. Strahlenther Onkol 2000;176:3-8.
12. Mock U, Bogner J, Georg D, Auberger T, Potter R. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Strahlenther Onkol 2005;181:448-455.
13. Loeffler JS, Smith AR, Suit HD. The potential role of proton beams in radiation oncology. Semin Oncol 1997;24:686-695.
14. Suit H, Goldberg S, Niemierko A, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol 2003;42:800-808.
15. Suit HD. Protons to replace photons in external beam radiation therapy? Clin Oncol (R Coll Radiol) 2003;15:S29-S31.
16. Wilson RR: Radiological use of fast protons. Radiology 1946;47:487-491.
17. Yonemoto LT, Slater JD, Rossi CJ Jr, et al. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study. Int J Radiat Oncol Biol Phys 1997;37:21-29.
18. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-421.
19. Rossi CJ. Conformal proton beam therapy of prostate cancer - update on the Loma Linda University Medical Center experience. Strahlenther Onkol 1999;175(suppl 2):82-84.
20. Slater JD, Yonemoto LT, Rossi CJ Jr, et al. Conformal proton therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 1998;42:299-304.
21. Shipley WU, Tepper JE, Prout GR Jr, et al. Proton radiation as boost therapy for localized prostatic carcinoma. JAMA 1979;241:1912-1915.
22. Shipley WU, Verhey LJ, Munzenrider JE, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995;32:3-12.
23. Slater JD, Rossi CJ Jr, Yonemoto LT, et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 2004;59:348-352.
24. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin North Am 2001;28:555-565.
25. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294:1233-1239.
26. Cella L, Lomax A, Miralbell R. Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2001;49:217-223.